Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis (Q34235419)

31 July 2017

0 references

Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis (English)

1 reference

31 July 2017

0 references

0 references

0 references

Johanna Löhönen

2

0 references

Jouko Miettunen

object named as

Jouko Miettunen

series ordinal

5

0 references

Matti Isohanni

series ordinal

4

object named as

Matti Isohanni

1 reference

31 July 2017

3

Hannu Koponen

1 reference

31 July 2017

Johanna Koskinen

1

1 reference

PubMed ID

19386576

31 July 2017

language of work or name

English

0 references

publication date

22 April 2009

1 reference

31 July 2017

Schizophrenia Bulletin

1 reference

31 July 2017

36

1 reference

31 July 2017

6

1 reference

31 July 2017

1115-1130

1 reference

Effects of cannabis use on outcomes of psychotic disorders: systematic review

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Drug use and health among prison inmates

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Meta-analyses of the incidence and prevalence of schizophrenia: conceptual and methodological issues.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Alcohol and cannabis use in Urban, African American, first-episode schizophrenia-spectrum patients: associations with positive and negative symptoms.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Patterns, predictors and impact of substance use in early psychosis: a longitudinal study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Reasons for increased substance use in psychosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Lifetime prevalence of psychotic and bipolar I disorders in a general population

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Pattern and correlates of inpatient admission during the initial acute phase of first-episode psychosis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

A descriptive study of pathways to care among hospitalized urban African American first-episode schizophrenia-spectrum patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Methods for analysis of skewed data distributions in psychiatric clinical studies: working with many zero values

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Clinical signs of cerebellar dysfunction in schizophrenia, alcoholism, and their comorbidity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Schizophrenia in homeless persons: a systematic review of the literature

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Cannabis and schizophrenia. A longitudinal study of Swedish conscripts

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Early adolescent cannabis exposure and positive and negative dimensions of psychosis.

6 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

Comparisons between schizophrenia patients recruited from Australian general practices and public mental health services.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

Prevalence and correlates of comorbidity 8 years after a first psychotic episode.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

Patterns of current and lifetime substance use in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

Comorbidity of substance abuse and other psychiatric disorders in acute general psychiatric admissions: a study from Lebanon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

Factors affecting hospital length of stay: is substance use disorder one of them? A study in a Greek public psychiatric hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

The role of alcohol and drugs in homicides in England and Wales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

Substance abuse in hospitalized psychiatric patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

The reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in psychosis.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Schizophrenic patients without neuropsychological deficits: subgroup, disease severity or cognitive compensation?

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

A comparative study on schizophrenic patients with dual diagnosis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963055

Substance use in a population-based clinic sample of people with first-episode psychosis

28 October 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP031

Comorbid substance-use in schizophrenia: relation to positive and negative symptoms

21 January 2018

1 reference

12 December 2020

Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up

1 reference

12 December 2020

Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups

1 reference

12 December 2020

Sex differences in illness presentation, course, and level of functioning in substance-abusing schizophrenia patients

1 reference

12 December 2020

The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia

1 reference

12 December 2020

Is Substance Abuse in Schizophrenia Related to Impulsivity, Sensation Seeking, or Anhedonia?

1 reference

12 December 2020

Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity

1 reference

12 December 2020

Predictors and outcome characteristics associated with suicidal behaviour in early psychosis: a two-year follow-up of first-admitted subjects

1 reference

12 December 2020

Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes

1 reference

12 December 2020

Lower negative symptom scores among cannabis-dependent patients with schizophrenia-spectrum disorders: preliminary evidence from an African American first-episode sample

1 reference

12 December 2020

Identifiers

DOI

10.1093/SCHBUL/SBP031

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

PubMed ID

19386576